News outlets around the world, including World Economic Forum, continue to report on research led by Jonathan Lovell showing that a new technique could help increase the effectiveness of vaccines against the novel coronavirus.

The Medical News reported on a technique developed by biomedical engineer Jonathan Lovell that could help increase the effectiveness of vaccines against the novel coronavirus, the virus that causes Covid-19.

Advanced Science News ran a story about a research team led by biomedical engineer Jonathan Lovell that has discovered a technique that could help increase the effectiveness of vaccines against the novel coronavirus, the virus that causes COVID-19.

Buffalo Business First reports on the progress of two UB-affiliated companies. UB spinoff POP Biotechnologies has announced a $3 million investment and formation of a joint venture with Eubiologics for the development of an RSV vaccine and other vaccine candidates. Jonathan Lovell, associate professor of biomedical engineering, is co-founder of the company.

An article in Genetic Engineering & Biotechnology News reports that a research team that includes UB’s Jonathan Lovell, associate professor of biomedical engineering, has identified an approach that improves drug delivery to tumor sites.